Begin main content

About CADTH Scientific Advice

The CADTH Scientific Advice Program is a voluntary, non-binding, and confidential fee-for-service consultation. Through this Program, pharmaceutical companies are provided with advice on their early drug development plans from a Canadian health technology assessment perspective.

What’s New

The CADTH Scientific Advice Program now offers a new level of responsiveness and flexibility to better meet the needs of the pharmaceutical industry. In the fast-paced and demanding environment of drug development, a one-size-fits-all approach simply isn’t optimal. Applicants may now inquire about:

  • customized timelines
  • more timely advice for smaller requests
  • obtaining advice at multiple time points along their early drug development plans.

We welcome your inquiries. Please contact us at requests@cadth.ca to see how we can work with you to address your needs.

Note: We are currently revising our Scientific Advice web pages. Please stay tuned for updates.